Combigene AB (COMBI) — Capital Reinvestment Ratio

Latest as of December 2021: 0.01x

Combigene AB (COMBI) has a Capital Reinvestment Ratio of 0.01x as of December 2021, meaning it reinvests 0% of its operating cash flow (Skr22.11 Million) in capital expenditures (Skr147.73K). Check Combigene AB (COMBI) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

Skr22.11 Million
SEK

Capital Expenditures

Skr147.73K
SEK

Data as of

Dec 2021
Most recent filing

Combigene AB Capital Reinvestment Ratio (2018–2021)

This chart tracks Combigene AB's Capital Reinvestment Ratio across 2 annual periods. For the full cash flow conversion analysis, see COMBI operating cash flow.

Annual Capital Reinvestment Ratio for Combigene AB (2018–2021)

Year-by-year Capital Reinvestment Ratio for Combigene AB from 2018 to 2021. See Combigene AB (COMBI) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (SEK) Capital Expenditures YoY Change
2021 0.01x Skr22.11 Million Skr147.73K ▼ -99.6%
2018 1.89x Skr227.60K Skr430.20K
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow